# Growing Demand for Whole Genome Interpretation | Simplify Genomics

- Canonical URL: https://wefunder.com/feed/349087
- Entity ID: wefunder:feed_item:349087
- Published at: 2026-07-07 20:33:04 UTC
- Updated at: 2026-07-08 19:55:28 UTC

## Author
Travis Lacey

## Subject
Simplify Genomics

## Content
Whole genome sequencing is becoming more accessible. That is good for patients, physicians, and healthcare organizations.But sequencing is only the beginning.A genome can produce millions of data points. Without interpretation, most of that information is difficult to use in care. Physicians need to know what is relevant, what is actionable, what should be monitored, and what may help explain a patient’s health risks.Simplify focuses on the work that happens after sequencing: interpretation, reporting, search, compliance, and workflows that make genomic information easier to understand and use.We are seeing interest across several areas of care. Preventive health programs want better ways to identify risk earlier. Executive health and longevity programs are looking for more personalized insight. Rare disease organizations need tools that can help surface possible genetic causes. Pharmacogenomics can help inform how certain patients may respond to medications.These are different use cases, but they all point to the same need: making genomic data clinically useful.That is the role that Simplify fills. As more organizations explore whole genome sequencing, the need for interpretation becomes more important.The bridge round is intended to support this next stage of commercialization, including partnership execution and the work required to bring whole genome interpretation into more clinical and enterprise settings.If you're interested in participating in this bridge round, the offering is available to accredited investors. If you're ready to move forward or are unsure whether you qualify, simply leave a comment below, schedule a call with our team, or email us at investors@simplifygenomics.com. We're happy to explain the accreditation process and answer any questions.